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To determine the prevalence and correlates of echocar•
diographic left ventricular hypertrophy among subjects 
in a general population, we studied 621 employed sub•
jects. Patients with uncomplicated essential hypertension 
in a worksite-based treatment program included 145 with 
borderline hypertension and 316 with sustained hyper•
tension by World Health Organization criteria. Nor•
motensive subjects were randomly selected from mem•
bers of the same unions. M-mode echocardiographic left 
ventricular dimensions were used to calculate left ven•
tricular mass and other indexes of left ventricular anat•
omy. The specificity of 13 echocardiographic criteria of 
left ventricular hypertrophy was determined in nor•
motensive individuals, and the prevalence of left ven•
tricular hypertrophy by each criterion was assessed in 
patients with borderline or sustained essential hyper•
tension. 
The results suggest that the most suitable reference 
Among patients with essential hypertension, cardiac hy•
pertrophy is considered an adaptation to increased blood 
pressure, although it may be detected even before arterial 
blood pressure elevation has become fixed (1). The presence 
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standard for detection of left ventricular hypertrophy in 
a heterogeneous urban population utilizes sex-specific 
cutoff values for left ventricular mass index of 110 g/m2 
or greater for women and 134 g/m2 or greater for men. 
With 97 % specificity, the prevalence of left ventricular 
hypertrophy by these criteria is approximately 12 % among 
patients with borderline hypertension and 20% among 
patients with relatively mild, uncomplicated sustained 
essential hypertension. Wall thickness measurements 
performed slightly less well. 
At similar levels of blood pressure, black patients 
were more likely than white patients to exhibit concentric 
left ventricular hypertrophy, especially among border•
line hypertensive patients. Left ventricular hypertrophy 
occurred in patients with sustained hypertension who 
also exhibited increased cardiac output, strongly asso•
ciated with low plasma renin activity. 
(J Am Coli CardioI1986;7:639-S0) 
of left ventricular hypertrophy is associated with a greater 
prevalence of disease in other target organs (2), and a higher 
incidence of subsequent cardiovascular morbidity and mor•
tality (3,4). However, most studies have shown relatively 
poor correlation between blood pressure and left ventricular 
hypertrophy. This suggests that other factors may be involved. 
Present knowledge of left ventricular hypertrophy is de•
rived from invasive and noninvasive cardiac studies of pa•
tients with hypertension. Cardiac catheterization has not 
been used to study defined free-living populations, but rather 
variably selected populations. As a result, most population 
data on left ventricular hypertrophy have been obtained from 
autopsy, electrocardiography, X-ray or echocardiographic 
studies. The prevalence of left ventricular hypertrophy de•
tected by these methods in patients with hypertension has 
varied not only among studies utilizing different methods 
but even among those in which the same method is used. 
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Autopsy studies (5,6) have reported prevalence rates of 46 
to 61 %, electrocardiographic studies (3,7-15) have reported 
prevalence rates ranging from less than I to 52% and echo•
cardiographic studies (l5.I 6) have reported the prevalence 
of left ventricular hypertrophy to vary between 23 and 48% 
in clinical populations. 
Some of this variability in the prevalence of left ven•
tricular hypertrophy among patients with hypertension may 
reflect methodologic difficulties. Electrocardiography and 
chest roentgenography assess left ventricular hypertrophy 
only indirectly, and have limited sensitivity when criteria 
with acceptable levels of specificity are used (17-20). Nec•
ropsy methods, although precise, can only be applied to 
highly selected populations. 
Recently, echocardiography has made it possible to di•
rectly visualize left ventricular wall thickness and chamber 
dimensions and to calculate left ventricular mass by both 
M-mode (21,22) and two-dimensional techniques (23,24). 
Preliminary studies (3,25) have demonstrated the suitability 
of this technique for study of free-living populations. The 
present study was undertaken, accordingly, to evaluate in 
normotensive and hypertensive members of an adult em•
ployed population: I) the prevalence of left ventricular hy•
pertrophy according to several proposed echocardiographic 
reference standards for its detection, and 2) the demographic 
and clinical factors associated with the presence of left ven•
tricular hypertrophy in the general population. 
Methods 
Subjects. Members of a well defined working popula•
tion comprising members of eight labor unions in New York 
City were examined. Individuals with hypertension were 
identified through screening at work locations and at affil•
iated union-sponsored diagnostic health centers. To be ad•
mitted into the worksite treatment program, patients either 
had a mean of three blood pressure readings taken at 1 week 
intervals of 160/95 mm Hg or greater or were taking anti•
hypertensive medication. A total of 4,602 patients have been 
enrolled in the worksite treatment program. Only the 3,338 
patients who entered the treatment program after January 
1981 were eligible for inclusion in the present study. The 
second eligibility criterion, geographic convenience to the 
New York Hospital-Cornell University Medical Center, was 
met by 1,112 patients. The third eligibility criterion was the 
ability of treated patients to be withdrawn from antihyper•
tensive medication for at least 3 weeks before study. Thirty 
percent of the patients could not be withdrawn from anti•
hypertensive medication because of clinical considerations 
(for example, presence of excessively high blood pressure 
or evidence of target organ damage). Thus, in all, 778 
patients were eligible. These patients were all invited to 
participate in the study and 662 (80%) came to Cornell 
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Medical Center for an echocardiogram and other laboratory 
studies. Of these 662 patients, 132 (20%) were excluded 
because their echocardiograms were not of optimal quality, 
leaving 530 eligible patients. The first 461 of these are 
included in this study. 
Classification of hypertensive groups. The 461 studied 
patients were divided into two groups according to the World 
Health Organization'S classification of hypertension. Blood 
pressure used in this study was measured by mercury ma•
nometer with subjects resting supine at the end of echocar•
diographic examination, using the first and fifth phases of 
Korotkoffs sounds. These pressures thus reflect the effect 
of 20 minutes or more of supine rest. Although alI subjects 
had previously met entry criteria for admission to the treat•
ment program, at the time of the echocardiographic study 
those with a systolic blood pressure of 140 to 159 or a 
diastolic blood pressure of 90 to 94 mm Hg, or both, were 
classified as patients with borderline hypertension (145 pa•
tients) and those with systolic blood pressure of at least 160 
or diastolic blood pressure of at least 95 mm Hg, or both, 
were classified as patients with sustained hypertension (316 
patients). 
Normotensive group. Normotensive subjects were se•
lected from 8,760 union members who participated in work•
site screening and were found to have normal blood pres•
sure. The 160 subjects were selected randomly after 
stratification to reflect the age, sex and race distribution of 
the total working population in the New York metropolitan 
area. When a population under study is composed of 
subgroups, as ours is (for example, men and women, blacks 
and whites), stratified sampling is the best method to assure 
proportional representation of each subgroup in the sample. 
In such instances, stratification provides a higher precision 
of estimates than other sampling techniques, and random 
selection within each stratum allows us to obtain unbiased 
estimates for them. 
Echocardiographic methods. M-mode echocardio•
grams were performed with the patient in the partial left 
decubitus position using 13 mm 2.25 MHz transducers and 
either a Picker Echoview 20C or Smith-Kline Ekoline ech•
ograph with a Honeywell 1856A strip chart recorded on 
light-sensitive paper at 50 mrnls. 
Echocardiographic recordings were coded and read blindly 
and in random order by two investigators who had no knowl•
edge of the subjects' blood pressure or other clinical data, 
including their classification as normotensive or hyperten•
sive. Only tracings that demonstrated optimal visualization 
of left ventricular interfaces were used, a requirement that 
resulted in exclusion of 19.4% of potential subjects. Left 
ventricular measurements were made as previously de•
scribed from this laboratory (26), according to the recom•
mendations of the American Society of Echocardiography 
(27) and Penn conventions (22). 
Penn convention measurements were used in an anatom-
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ically validated formula to calculate left ventricular (LV) 
mass (21,22): 
LV mass (Penn) = \.04[(lVS + LVID 
+ PWT)3 - (LVID)3] - 13.6 g, 
where IVS = interventricular septal thickness, LVID = 
left ventricular internal dimension and PWT = posterior 
wall thickness, Measurements of left ventricular mass were 
divided by body surface area to obtain left ventricular mass 
index, Lean body mass was calculated from 24 hour urinary 
creatinine excretion (28) and left ventricular mass was di•
vided by lean body mass to obtain left ventricular mass 
indexed by lean body mass, 
American Society of Echocardiography (ASE) measure•
ments were used in the cube function formula to calculate 
left ventricular mass (ASE) (3): 
LV mass(ASE) = \'04[(IVS + LVID + PWT)3 - (LVID)3], 
as well as cardiac output (CO), total peripheral resistance, 
end-diastolic relative wall thickness and percent fractional 
shortening of the left ventricular minor axis by standard 
formulas (29,30), 
Echocardiographic criteria of left ventricular hyper•
trophy. A variety of echocardiographic measurements have 
been used to detect left ventricular hypertrophy in patients 
with hypertension, These have included primary measure•
ments such as thickness of the posterior left ventricular wall 
or interventricular septum (31,32), and derived variables 
such as left ventricular mass and mass index (15,16,26), 
relative wall thickness (30,33) and cross-sectional area of 
the left ventricular myocardium, However, little is known 
of the distribution of these variables among clinically normal 
subjects, or the ability to use these echocardiographic mea•
surements to detect left ventricular hypertrophy among pa•
tients with hypertension in a free-living population by use 
of available "normal" reference standards. Accordingly, 
the upper 95% confidence limit of normal for each primary 
and derived echocardiographic variable previously estab•
lished in 225 normal subjects (34) was applied to the group 
of normotensive, borderline and sustained hypertensive 
indi viduals. 
In addition, several studies (3,34.35) have suggested that 
normal limits of left ventricular anatomic measurements 
should take into account the subjects' age, sex and body 
size. Of the available criteria based on indexation of echo•
cardiographic left ventricular mass, a unified criterion of 
120 g/m2 or greater in both sexes was introduced first (17), 
More recently (34), we developed sex-specific criteria of 
134 g/m2 or greater in men and 110 g/m2 or greater in 
women, based on upper 95% confidence limit cutoffs with 
the advantage of easy applicability, The Framingham group 
(3) proposed sex-specific reference standards based on 
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regression equations derived from a large, apparently nor•
mal population, which may potentially be more precise be•
cause of possible mathematical optimization but also harder 
to apply because of complex formulas. 
Statistical methods. Descriptive statistics. The distri•
bution of values for each primary and derived variable and 
for each variable indexed for body surface area and for lean 
body mass was plotted for visual inspection. Normally dis•
tributed variables were described by the mean and standard 
deviation of values for each group, and the median value 
was also determined for variables with skewed distribution. 
The proportion of individuals exhibiting left ventricular hy•
pertrophy by use of each echocardiographic measurement 
was determined by use of published upper 95% confidence 
limits (3,35). 
Univariate analyses. To test the differences between the 
means of more than two groups, the Kruskal-Wallis one•
way analysis of variance was used. The t test was used to 
test the differences between the means of two groups, if the 
variable had a normal distribution. and the Mann-Whitney 
U test was used for variables that had highly skewed dis•
tributions, for example, plasma renin, urinary sodium, po•
tassium, duration of hypertension and blood urea nitrogen, 
The chi-square test was used to test proportions. The sig•
nificance level was set at a = 0.05. Further univariate 
analysis was performed for those variables that were sig•
nificantly different among the three groups to determine 
which groups were different from the others. The test used 
for this was Duncan's multiple range test. 
Multivariate analyses. Clinical and demographic vari•
ables that were highly correlated to left ventricular mass 
were used in a multiple logistic regression analysis, em•
ploying the Newton-Raphson method of estimation, This 
method allows prediction of the maximal likelihood of an 
outcome event, in this case left ventricular hypertrophy, 
from measurements of both continuous variables (for ex•
ample, blood pressure) and discrete variables (for example, 
sex. race), Excellent performance of this method not only 
will yield a close correspondence between observed and 
predicted events. but also will result in a strikingly higher 
prevalence of left ventricular hypertrophy in the high risk 
group than in the low risk group, 
The following variables were included in the linear mul•
tiple logistic regression: age. sex, body surface area, race, 
systolic and diastolic blood pressures. plasma renin activity, 
duration of hypertension and blood urea nitrogen. The order 
in which these variables were listed is irrelevant to the 
analysis, because all the variables were evaluated as part of 
the analysis in a stepwise procedure to determine which 
variable should enter the regression model and in what order. 
The purpose of this analysis was to establish a clinical pre•
diction formula to elucidate the mechanism and to determine 
the relative importance of the different variables in causing 
left ventricular hypertrophy. 
642 HAMMOND ET AL 
LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION 
lACC Vol 7. No 3 
March J 986 639-50 
Table 1. Characteristics of Nonnotensive and Hypertensive Subjects 
Normotensive 
Subject> With Hyperten,wn 
Slgmficance 
Subjects Borderline Sustamed Level 
Variable (n = 160) (n = 145) (n = 316) (p) 
Age (yr) 44.0 ± 127 51.8 ± 99* 53.3 ± 9 8* 0.0001 
Systolic blood pressure (mm Hg) 1189 ± 11.0 139.2 ± 11.2* 156.6 ± 16.3*t 0.0001 
DIastolic blood pressure (mm Hg) 752 ± 7.6 83.3 ± 7.2* 992 ± 8.5*t 0.0001 
Heart rate (beats/mm) 67.7 :!: 12.8 68.5 :!: 10 0 69.5 :!: 11.6 NS 
Body surface area (m2 ) 1.83 :!: 0.21 1.89 ± 0.19 I 90 ± 0 19 00011 
Lean body mass (kg) 500 ± 16.2 494 ± 17.6 5!.7 ± 18.0 NS 
Plasma renin actIvity (ng/ml per h) 2.46 ± 1.93 1.78 ± 1.72 1.86 ± 1.98 0.0022 
Urinary sodium (mEq/24 h) 121.8 ± 53.5 107.8 ± 61.8 118.0 ± 660 0.0280 
Urinary potassium (mEq/24 h) 46.0 ± 20.2 54.4 :!: 26 I 55.8 ± 23.6 0.0002 
BUN (mg/dl) 15.7 ± 43 15.9 ± 4.2 15.9 ± 4.3 NS 
Serum creatlnme (mg/dl) 1.20 :!: 0.25 1.13 ± 0.24 1.18 ± 0.23 0.0172 
Females (%) 48 ± 6 35 ± 6 30 ± 8 0.0059 
Blacks (%) 49 :!: 6 36 :!: 6 38 ± 10 0.0013 
Duration (yr) 4.0:!: 3.0 3.5 :!: 3.0 NS 
Results of Duncan's multiple range test: *slgnificantly different from normotensive subjects; tsigmficantly different from subjects wIth borderline 
hypertension. Values are given as mean :!: SD. Significance level reported in thIS table represents the results of the Kruskal-Wallis one-way ANOVA. 
BUN = blood urea mtrogen; NS = not significant. 
Results 
Demographic and laboratory findings (Table 1). 
Normotensive subjects and patients with borderline and sus•
tained hypertension were identical with respect to lean 
body mass, heart rate and blood urea nitrogen. There were 
significant statistical differences (by analysis of variance) 
in the means of the following demographic and laboratory 
variables: age, body surface area, systolic blood pressure, 
diastolic blood pressure, plasma renin activity, 24 hour uri•
nary sodium and potassium and percent women and blacks. 
Using Duncan's multiple range test, the means of the three 
groups were distinctly different from each other with respect 
to blood pressure. 
A comparison of demographic and clinical characteristics 
between the hypertensive patients included in this study and 
the remaining hypertensive patients not included showed no 
significant differences in any of the variables reported, ex•
cept that the' hypertensive patients in this study had lower 
blood pressure than the remaining hypertensive population. 
This difference reflected exclusion of more severely hyper•
tensive patients judged clinically unable to be withdrawn 
from antihypertensive medication. Although hypertensive 
men were more likely than hypertensive women to be ex•
cluded on this basis, this difference did not attain statistical 
significance. The normotensive subjects in this study had 
almost identical characteristics compared with the remaining 
normotensive population. 
Left ventricular structure and function (Table 2). 
Analysis of variance revealed that the three groups dif•
fered significantly in all echocardiographic variables except 
left ventricular fractional shortening, which was insignifi•
cantly higher in the groups of hypertensive patients. The 
distribution of values for the echocardiographic measure•
ments in the three groups is presented in Figure 1. Duncan's 
multiple range test revealed that the least overlap in values 
for patients with borderline and sustained hypertension oc•
curred for left ventricular end-diastolic relative wall thick•
ness and mass indexed by lean body mass. As expected 
from previous studies, blood pressure elevation in patients 
with borderline hypertension was associated mainly with an 
increased cardiac index (1 I % greater than that in normo•
tensive subjects), with only a 5% increase in total peripheral 
resistance index, whereas patients with sustained hyperten•
sion exhibited an 18% increase in resistance in combination 
with a 12% increase in cardiac index. That the increased 
pump performance of the heart is not due to overcompen•
satory left ventricular hypertrophy in relation to hemody•
namic load is indicated by the stepwise increase in end•
systolic left ventricular waIl stress in the hypertensive groups. 
Prevalence of left ventricular hypertrophy (Tables 3 
to 5). The overall prevalence of left ventricular hypertrophy 
as determined by the various echocardiographic reference 
standards is given in Table 3. The proportion of apparently 
normal individuals labeled as having left ventricular hy•
pertrophy by the different criteria varies from 1.3% using 
a cutoff of 140 g/m2 to 9.4% using the Framingham sex•
specific reference standards. The sex-specific criteria of left 
ventricular hypertrophy previously proposed from this lab•
oratory identified 3.1 % of normotensive individuals as hav•
ing left ventricular hypertrophy, resulting in 97% specific•
ity. The latter sex -specific criteria detected the highest 
proportion of hypertensive patients having left ventricular 
hypertrophy and resulted in the clearest stepwise increase 
in prevalence of left ventricular hypertrophy from normal 
subjects to patients with sustained hypertension of any ref-
JACC Vol. 7, No 3 
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Table 2. Echocardiographic Findings in Normotensive and Hypertensive Subjects 
Normotensive 
Subjects With Hypertension 
Significance 
Subjects BorderlIne Sustamed Level 
Variable (n = 160) (n = 145) (n = 316) (p) 
IVS (cm) 0.94 ± 0.17 1.07 ± 0.18* 1.11 ± 0.21* 0.0001 
LVID (cm) 4.81 ± 0.53 495 ± 057 4.99 ± 0.54 0.0009 
PWT (cm) 0.84 ± 0 15 0.93 ± 0 17* 0.98 ± 0.17* 0.0001 
RWT 0.35 ± 0.07 0.38 ± 009* 0.40 ± 008*t 0.0001 
CSA (cm2) 16.0 ± 3.4 18.7 ± 3.6* 19.9 ± 44* 0.0001 
CSA index (cm2/m2) 8.8 ± 1.5 9.8 ± 1.8* 10.4 ± 2.0* 0.0001 
LV mass (Penn) (g) 154.9 ± 50.3 189.2 ± 54.0* 208.0 ± 71.0* 00001 
LV mass (ASE) 192.6 ± 55.1 233 7 ± 61.8* 253.0 ± 77.2 0.0001 
L VM index (g/m2) 84.0 ± 227 99.8 ± 25.8* 108.2 ± 314* 0.0001 
L VMllean body mass (g/kg) 3.31 ± 1.25 4.17 ± 2.20* 4.42 ± 2.28*t 0.0001 
Cardiac output (mllmm) 5,507 ± 1,921 6,248 ± 2,295 6,391 ± 2,090 0.0001 
CardIac index (mllmin per m2) 3,004 ± 914 3.345 ± 1,168 3.357 ± 990 0.0008 
TPR x 103 (dynes-cmls5) 1.45 ± 050 1.47±058 1.64 ± 057 0.0001 
TPR index 2.60 ± 0.83 2.73 ± I 04 3.06 ± 0.98 0.0001 
ESWS x 103 (dynes-cm2) 63.0 ± 21.3 700 ± 27.7* 77.1 ± 26.9*t 0.0001 
Fractional shortening (%) 35.0 ± 5.5 36.7 ± 6.7 36.9 ± 6 7 NS 
Results of Duncan's multiple range test: *significantly dIfferent from normotensIve subjects; tsignificantly different from subjects with borderline 
hypertension. Values are given as mean ± SO. Slgmficance level reported in this table represents the results of the Kruskal-Wallis one-way ANOVA. 
CSA = cross-secttonal area; ESWS = end-systolic wall stress; IVS = mterventncular septal thickness, LV = left ventricular; LVID = left ventricular 
internal dimension; L VM = left ventricular mass; PWT = postenor wall thickness; RWT = relative wall thickness; TPR = total peripheral resistance. 
erence standard with approximately 97% or higher speci•
ficity. Even higher specificity (approximately 99%) could 
be achieved by using a cutoff of left ventricular mass index 
of 140 g/m2, but at the cost of substantially reducing the 
number of hypertensive patients in whom left ventricular 
hypertrophy was detected. 
The prevalence of left ventricular hypertrophy by sex 
(male versus female) as determined by use of the various 
echocardiographic criteria is presented in Table 4, and the 
prevalence of left ventricular hypertrophy by race (black 
versus white) as determined by the different echocardio•
graphic criteria is presented in Table 5. Of note, the latter 
analysis demonstrated a substantially higher prevalence of 
left ventricular hypertrophy among black than among white 
patients with borderline hypertension, especially as detected 
by indexes of left ventricular wall thickness and relative 
wall thickness. 
Correlates of left ventricular hypertrophy (Table 6). In 
the stepwise linear multiple logistic regression, we found 
that left ventricular hypertrophy by sex-specific reference 
standards was associated among normotensive patients with 
higher systolic blood pressure and a positive smoking his•
tory, whereas increasing age was the only variable statis•
tically associated with left ventricular hypertrophy among 
patients with borderline hypertension. In patients with sus•
tained hypertension, male sex, low plasma renin and ele•
vated blood urea nitrogen were the variables significantly 
related to left ventricular hypertrophy by these sex-specific 
criteria. When left ventricular hypertrophy was defined by 
using left ventricular mass index of 140 g/m2 or greater, so 
few subjects were classified as having left ventricular hy•
pertrophy that we were unable to apply the multiple logistic 
regression. 
Ranks of prevalence ratios and simple attributable 
risk (Table 7). The overall prevalence rates of left ven•
tricular hypertrophy among normotensive subjects were 
ranked, the lowest assigned the rank of 1 and the highest 
the rank of 13. The ratio of prevalence rates by each echo•
cardiographic criterion observed among hypertensive pa•
tients in relation to the normotensive population, as well as 
the difference in prevalence rates (population attributable 
risk), were also ranked. For the latter variables the highest 
was assigned the rank of 1 and the lowest the rank of 13. 
The overall performance of each criterion was ranked using 
the sum of the four scores, with a low sum being desirable. 
The sex-specific criteria for left ventricular mass gave the 
most consistent results with regard to detecting left ven•
tricular hypertrophy in a small proportion of apparently nor•
mal subjects and in a moderate proportion of patients with 
hypertension, while a cutoff of 140 g/m2 gave the best 
specificity but ranked second overall because it yielded a 
low attributable risk of left ventricular hypertrophy in sus•
tained hypertensive patients. 
Differences between patients with sustained hyper•
tension with and without left ventricular hypertrophy 
(Table 8). Patients with sustained hypertension who had 
left ventricular hypertrophy as defined by sex-specific cri•
teria for left ventricular mass differed significantly in clinical 
and echocardiographic variables from those without left ven•
tricular hypertrophy, although systolic and diastolic blood 
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pressure were similar in the two groups. Of note, the patients 
with left ventricular hypertrophy had significantly higher 
cardiac output associated with lower plasma renin activity 
and urinary potassium excretion, and a higher so•
dium/potassium ratio, compared with patients without 
hypertrophy, 
The results presented in Tables 6, 7 and 8 were similar 
in both black and white subjects, 
Discussion 
For a criterion to be useful for detecting left ventricular 
hypertrophy in population studies, it should be anatomically 
validated, have high specificity in a general nondiseased 
population and be sensitive for the detection of left ven-
"' 'f .. .. 
IVSd (em) 
LVIDd (em) 
N <D .. <D .n '" ~ "' A' q "' '" .n .0 
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Figure 1. Distribution of values for 
echocardiographic measurement of left 
ventricular mass index (LVMI), inter•
ventricular septal thickness (lVSd). pos•
terior wall thickness (PWTd) and left 
ventricular internal dimension (L VIDd) 
in the three patient groups, 
tricular hypertrophy. Anatomic validity of our echocardio•
graphic methods of determining left ventricular mass using 
the Penn (22) and American Society of Echocardiography 
(27) measurements was demonstrated in two independent 
necropsy correlation studies encompassing 34 and 52 sub•
jects, respectively (21,22). In both studies close correlations 
(r = 0.90 to 0,96, p :s 0.0001) were observed in all com•
parisons between values for left ventricular mass assessed 
at necropsy and echocardiography. Similar data validating 
left ventricular mass based on American Society of Echo•
cardiography measurements were recently published by 
Woythaler et al. (36). In our two necropsy populations (21,22), 
the overall sensitivity and specificity of the echocardio•
graphic diagnosis of left ventricular hypertrophy compared 
with necropsy measurements were 97 and 89%, respec-
JACC Vol 7, No.3 
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Table 3. Prevalence of Left Ventricular Hypertrophy by Echocardiographic Criteria* 
NormotensIve 
SubJecb With Hypertension 
Subjects Borderline SustaIned 
Cnterion (n = 160) (n = 145) (n = 316) 
LVMFt 94 (8.8, 10.0) 19.6 (18.9, 20.3) 30.1 (29 2, 31.0) 
LVMSSt 3.1 (2.8, 3.4) 12.4 (II 8, 13.0) 19.4 (\8.6. 20.2) 
LV mass 
>120 g/m2 7.5 (70,8.0) 17.4 (\6.7,18.1) 21.1 (20.3,21.9) 
>125 g/m2 4.4 (4.0, 4.8) 13.0 (12.4, 13.6) 16.7 (16 0,17.4) 
>130 g/m2 3.1 (2.8, 3.4) 11.6 (\ I 0, 12.2) 14.1 (\ 3.4, 14.8) 
> 135 g/m2 1.9 (1.6,2.2) 8 7 (8.2, 9 2) 1\.7 (\1 1,123) 
>140 g/m1 13(1.1,15) 8 0 (7 5, 8.5) 9.0 (8.4, 96) 
IVS:::: 1.28 cm 3.8 (3.4, 4.2) 123 (\ I 7, 12.9) 184 (17.6,19.2) 
L VID :::: 6.00 cm I. 9 (1.6, 2.2) 2.9 (2 6, 3.2) 4.8 (44, 5.2) 
PWT:::: 1.13 cm 3 8 (3.4, 4 2) 14.5 (13.8, IS 2) 16.4 (15.7,17 I) 
IVS/PWT :::: I 50 3 I (2 8, 3 4) 5.1 (47,5.5) 2.0 (\.7,2.3) 
RWT:::: 0.49 3.8 (3.4, 4.2) 10.1 (9.5. 10 7) 12.0 (II 4, 12.6) 
CSA :::: 22 8 3.8 (3.4, 4 2) 10.1 (95, 10.7) 18.4 07.6,19.2) 
* Prevalence 95% confidence interval tSee text for descnption of cutoff determInatIon. L VMF = 
Framingham criteria for left ventricular mass (3); LVMSS = Sex-specific critena for left ventncular mass (34); 
other abbreviations as in Table 2. 
tively. The relatively low specificity of echocardiographic 
left ventricular mass (89%) in the combined results of these 
studies was due to admixture of patients with severe left•
sided heart disease whose left ventricular mass fell just 
below the upper limit of normal, because specificity of echo•
cardiographic left ventricular mass index by our sex-specific 
criteria was 96% in 27 necropsy subjects without left ven•
tricular disease. 
Specificity of echocardiographic criteria. Left ventric•
ular mass. Most available echocardiographic criteria have 
cutoff points based on the upper 95% confidence limit of 
normal, with an expected prevalence rate of abnormal values 
of approximately 3% among apparently normal SUbjects. 
Several criteria, including the sex-specific criteria previ•
ously proposed (34) from our laboratory, achieved this goal 
in the present study. A preliminary cutoff of 120 g/m2, 
Table 4. Prevalence of Echocardiographic Left Ventricular Hypertrophy by Sex 
Subjects With Hypertension 
Normotensive Subjects Borderline SustaIned 
(n = 160) (n = 145) (n = 316) 
Female Male Female Male Female Male 
(n = 76) (n = 84) (n = 51) (n = 93) (n = 93) (n = 222) 
Criterion (%) (%) (%) (%) (%) (%) 
LVMF* 14.5 48 25.5 17.2 44.1 23.9 
LVMSS* 2.6 36 13.7 11.8 290 14.0 
LV mass 
>120 g/ml 1.3 13 I 98 21 5 IS I 22 I 
>125 g/m2 1.3 7.1 5.9 17.2 97 18.5 
>130 g/m2 I 3 4.8 5.9 15.1 6.5 16.2 
>135 g/m2 1.3 24 5.9 9.7 5.4 13.5 
>140 g/m2 1.3 12 59 8.6 32 10.8 
IVS :::: 1.28 cm 2.6 4.8 98 140 12.9 21.6 
LVID :::: 6.00 cm 0.0 3.6 3.9 2.2 2.2 5.9 
PWT:::: I 13 cm 66 1.2 13.7 16.1 12.9 18.5 
IVS/PWT:::: 1.50 40 2.4 7.8 3.2 1.1 2.3 
RWT:::: 0.49 79 00 13.7 8.6 108 13.1 
CSA :::: 22.8 1.3 6.0 7.8 14.0 7.5 23.0 
*See text for descriptIOn of cutoff determInatIon. AbbreVIations as In Tables 2 and 3. 
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Table 5. Prevalence of Echocardiographic Left Ventricular Hypertrophy by Race 
HypertensIve Subjects 
Nonnotensive Borderl1Oe Sustamed 
Subjects (n = 145) (n = 316) 
Black WhIte Black WhIte Black WhIte 
(n = 73) (n = 72) (n = 49) (n = 62) (n = 114) (n = 124) 
Criterion (%) (%) (%) (%) (%) (%) 
LVMF* 9.6 97 26.5 16.1 37.7 26.6 
LVMSS* 4 I 2.8 16.3 8.2 21.1 19.4 
LV mass 
>120 g/m2 9.6 6.9 18.4 14.5 24.6 21.0 
>125 g/m" 5.5 4.2 14.3 8.1 20.2 17.7 
>130 g/m" 2.7 4.2 14.3 6.5 15.8 16.1 
> 135 g/m" 2.7 1.4 10.2 6.5 12.3 14.5 
>140 g/m" 2.7 0.0 8.2 6.5 10.5 10.5 
IVS "'" 1.28 cm 5.5 2.8 163 12.9 23.7 17.7 
LVID "'" 6.00 cm 2.7 1.4 0.0 4.8 3.5 7.3 
PWT"", 1.13 cm 4.1 2.8 24.5 11.3 246 14.5 
IVS/PWT "'" 1.50 5.5 1.4 20 8.1 1.8 3.2 
RWT "'" 0.49 5.5 1.4 184 6.5 17.5 9.7 
CSA "'" 22.8 5.5 2.8 16.3 8.1 219 19.4 
*See text for description of cutoff detenn1Oation Abbreviations as in Tables 2 and 3. 
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which we previously proposed (17), showed a lower spec•
ificity in this large un selected population of apparently nor•
mal individuals than in a smaller population of sedentary 
individuals without cardiovascular disease reported earlier 
(26). 
diographic methods at Cornell and Framingham and applied 
them in several studies, including joint readings of echo•
cardiograms (26,37,38). It seems more likely that differ•
ences in the populations studied by the two centers may 
account for the differences in results of using the Fram•
ingham sex-specific standards. The data in Table 4 indicate 
that the reduction in specificity of Framingham sex-specific 
criteria occurred primarily among women in our population. 
Analysis of normotensive women classified differently by 
the two sets of sex-specific criteria revealed that the major 
discrepancy occurred among women who were under 50 
Another promising standard for left ventricular mass de•
rived by the Framingham study, based on echocardiograms 
from a large population of apparently normal subjects. had 
a lower specificity (91 %) in the present study population. 
Differences in echocardiographic methods can be excluded 
as the explanation, because we have coordinated echocar-
Table 6. Prediction of Left Ventricular Hypertrophy by Demographic and Clinical Variables* 
Variables Beta SE Chi-Square p Value 
Nonnotensive subjects 
Intercept - 21.6886 9.0033 
Smoking historyt 0.7441 0.2606 8.15 0.0043 
Systolic BP (mm Hg) 0.1393 0.0680 4.19 0.0406 
Subjects wIth borderline hypertension 
Intercept - 9.4165 3.6687 
Age (yr) 0.1263 0.0609 4.30 0.0381 
Subjects wIth sustained hypertension 
Intercept - 1.5890 0.7952 
Sext -1.3908 0.4472 9.67 0.0019 
Plasma renin -0.5337 o 1843 8.39 0.0038 
BUN (mg %) 0.1296 0.0500 6.72 0.0096 
*Left ventncular hypertrophy = left ventricular mass index"'" 110 g/m2 in women and"'" 134 g/m" 10 men. 
tValues assigned to discrete variables; sex: female = 0, male = J, smok1Og history: never smoked = 0, quit 
smoking = I, smokes I to 9 cIgarettes/day = 2, smokes 10 to 20 cigarettes/day = 3, smokes 20 + cigarettes/day 
= 4. BP = blood pressure; BUN = blood urea nitrogen 
lACC Vol 7. No 3 
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Table 7. Ranks of Prevalence Ratios and Simple Attributable Risk 
Overall 
Subjects With Hypertension 
Prevalence 
(nonnotensive Sustained/Nonnal Borderline/Nonnal 
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subjects) Ratio RatIo Attributable Risk Rank Total 
Cntenon Rank Ratio Rank Ratio Rank Rank Risk Total Rank 
LVMF* \3.0 3.2 95 2 I 11.0 20.7 1.0 34.5 90 
LVMSS* 50 63 20 4.0 3.0 163 20 12.0 1.0 
LV mas, 
>120 g/m2 12.0 2.8 11.0 2.3 10.0 13.6 5.0 38.0 11.0 
> 125 g/m2 11.0 3.8 8.0 3.0 7.0 12.3 7.0 33.0 8.0 
> 130 g/m2 5.0 45 6.0 37 5.0 11.0 80 24.0 5.0 
> 135 g/m2 2.5 62 30 46 2.0 9.8 90 16.5 30 
>140 g/m2 1.0 69 10 6.2 1.0 7.7 11.0 14.0 20 
IVS 2: 1.28 cm 8.5 4.8 4.5 32 6.0 14.6 35 22.5 4.0 
LVID 2: 6.00 cm 2.5 25 120 1.5 13.0 29 12.0 39.5 12.0 
PWT 2: 1.13 em 8.5 4.3 7.0 3.8 4.0 12.6 6.0 25.5 7.0 
IVS/PWT 2: 1.50 50 0.7 13.0 1.6 120 -1.1 \30 43.0 13.0 
RWT 2: 0.49 8.5 3.2 95 2.7 8.5 8.2 10.0 36.5 100 
CSA 2: 22 8 85 4.8 4.5 27 8.5 14.6 35 25.0 6.0 
*See text for descriptIOn of cutoff detenninatlOn AbbreviatIOns a, m Table~ 2 and 3. 
years of age, in whom left ventricular mass index values of 
less than 110 g/m2 fell within our normal range but above 
the Framingham cutoff values, which range as low as 93 
g/m2 for lean women in their 20s (Savage DD, personal 
communication, 1985). 
One possible explanation is that the two populations 
(Cornell and Framingham) may differ in the proportion of 
younger women who are physically active in the course of 
everyday activities. For example. New York City residents 
walk extensively, climb several flights of steps to subways 
Table 8. Characteristics of Sustained Hypertensive Patients With and Without Left 
Ventricular Hypertrophy 
LVMSS LVH LVMSS No LVH 
Vanable (n = 58) (n = 257) 
Age (yr) 55.3 ± 10.0 52.8 ± 9.8 
Body ,urface area (m2) 191 ± 023 1.89 ± 0.18 
Blood pressure 
Systolic 1599 ± 15.7 1557 ± 16.4 
Diastolic 99.3 ± 8.4 99.3 ± 8.5 
IVS (cm) 1.28 ± 0.24t 1.07 ± 0.18 
LVID (em) 5.26 ± 0 55:1: 4.93 ± 0.51 
PWT (cm) I 12 ± 0.20:1: 095 ± 0 15 
IVS/PWT 1.15 ± 0 18 1.14 ± 0.15 
L V mass (Penn) (g) 282.6 ± 89.1:1: 191.3 ± 53.6 
LVMI (g/m2) 146.4 ± 349t 96.1 ± 17.5 
LVMC (g/kg) 6.34 ± 3.0U 3.82 ± 1.59 
Cardiac output (ml/min) 6,881 ± 1,966* 6,270 ± 2.104 
TPR x 103 (dynes-cm/s5) 1.51 ± 0.47* 1.68 ± 0.58 
RWT (cm) 043 ± O.lOt 0.39 ± 0.08 
%FS 34.7 ± 8.1 36.1 ± 6.2 
ESWS x 103 (dynes/cm2) 793 ± 297 76.5 ± 26.3 
Plasma renm 1.28 ± 1.65t 2.00 ± 203 
Urinary sodium (mg/dl) 117.3 ± 662 118.4 ± 66.1 
Unnary potassium (mg/dl) 48.9 ± 20.6t 57.6 ± 23.9 
DuratIon (yr) 3.5 ± 0.9 3.6 ± 1.0 
*p < 0 OS; tp < 0.005; tp < 00001. %FS = percent fractional shortening of the left ventncular minor 
aXIs; L VH = left ventncular hypertrophy; L VMC = left ventncular mass/lean body mass index; L VMI = 
left ventricular mass/body surface area mdex; L VMSS = ,ex-specific critena of left ventricular mass; RWT 
= (2 x PWT)/L VID; other abbreViatIons a, m Table 2 
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or apartments and carry purchases from stores more fre•
quently in their daily life than do residents of other parts of 
the United States, where readier access to automobiles fa•
cilitates a more sedentary lifestyle. Women in our popu•
lation are actively employed in unions representing physi•
cally active occupations (for example, store workers). 
Left ventricular wall thickness. Wall thickness indexes 
achieved lower specificity than sex-specific left ventricular 
mass index among normotensive individuals. Thus, al•
though these are reasonable choices for study, they perform 
slightly less well with respect to specificity. Cross-sectional 
area performed similarly to primary waH thickness mea•
surements with 96% specificity. The only criterion attaining 
99% specificity was left ventricular mass index of 140 g/m2 
or greater. In hypertensive subjects, sex-specific left ven•
tricular mass index criteria detected the highest proportion 
of left ventricular hypertrophy with a specificity of at least 
97%. Indexes of wall thickness detected left ventricular 
hypertrophy in slightly lower proportions of patients with 
hypertension. Overall, little discrimination was achieved by 
left ventricular internal dimension and the ratio of inter•
ventricular septal thickness to posterior wall thickness, with 
a very low proportion of abnormal values. 
Septal thickness. Disproportionate septal thickness was 
slightly more prevalent in patients with borderline than in 
patients with sustained essential hypertension. This finding 
is consistent with an earlier observation by Lehner et al. 
(39). However, this result did not achieve statistical sig•
nificance because of a low prevalence of disproportionate 
septal thickness in the present hypertensive group. This low 
prevalence is similar to that previously reported from this 
laboratory (15 of 400 or 4%) in an earlier study (38) of 
patients with hypertension. 
Although sex-specific left ventricular mass index cutoff 
points performed best for detecting left ventricular hyper•
trophy in our free-living employed population with regard 
to both high specificity and ability to detect disease, other 
criteria may be equally suitable for study populations with 
differing characteristics. For instance, lower left ventricular 
mass index cutoff points might be more applicable in sed•
entary populations, as we have observed in previous studies 
heavily weighted toward relatively affluent office workers 
(26). 
Several factors suggest that our normotensive subjects 
provide an appropriate reference standard for study of em•
ployed urban populations. Our normal population is rela•
tively diverse ethnicaHy, reflecting faithfuHy the heteroge•
neity of the population of New York and many other urban 
centers. Our normal population also represents the spectrum 
of occupations, from the more sedentary occupations at one 
end, through low level management to physically active 
occupations at the other. 
Prevalence ofleft ventricular hypertrophy. The over•
all prevalence of left ventricular hypertrophy as defined by 
lACC Vol 7. No 3 
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a sex-specific reference standard was approximately 12% 
among patients with borderline hypertension and 20% in 
patients with sustained hypertension. These prevalence rates 
are higher than the 5% reported by electrocardiographic 
studies (14), but lower than rates reported from clinical 
studies using echocardiography (2,15,16,26,33,37). Clini•
cal studies from tertiary care centers overrepresent patients 
with severe hypertension, a high proportion of whom have 
target organ damage. Conversely, entry criteria for the pres•
ent study excluded roughly 30% of eligible patients with 
hypertension because their blood pressure was too high or 
their course was considered too complicated to be taken off 
antihypertensive medication for 3 weeks. Our patient pop•
ulation has mild to moderate essential hypertension as as•
sessed by both blood pressure recordings and the relatively 
low incidence of cardiovascular disease morbidity and mor•
tality we have previously reported (40,41). Use of actively 
employed patients has also excluded an additional propor•
tion of hypertensive patients whose hypertension has caused 
complications that have eliminated them from the work force. 
Adjustment of our prevalence rate for the effect of these 
negative selection biases would suggest that from 25 to 30% 
of all hypertensive patients would have left ventricular hy•
pertrophy by criteria with 97% specificity. 
Effect of sex and race on prevalence of left ventricular 
hypertrophy. Hypertensive men and women were com•
pared using sex-specific cutoff points for left ventricular 
mass and a surprising result emerged. There was a signif•
icantly higher prevalence of left ventricular hypertrophy 
among women than among men. Several factors may ex•
plain this finding. First, the upper normal limit by these 
criteria may be too high for men, because of the admixture 
of subjects who have clinically undetectable heart disease, 
in accord with the fact that the male sex is an independent 
predictor of cardiovascular morbidity (42). Long-term fol•
low-up of our population will, in the future, reveal those 
apparently normal subjects who had undetected heart disease 
at the time of initial study. Second, men with hypertension 
may be more likely to reduce their physical activity after 
the diagnosis of hypertension. Finally, hypertensive men 
with left ventricular hypertrophy who are known from pre•
vious electrocardiographic studies to be at increased risk of 
coronary artery disease probably were disproportionately 
excluded from this study because of concern that they might 
have morbid events when removed from medication to qual•
ify for inclusion in this study. This is compatible with the 
tendency for proportionately more men than women to be 
unable to be withdrawn from antihypertensive medication. 
Hypertensive men consistently have higher prevalence 
rates of left ventricular hypertrophy by non-sex-specific left 
ventricular mass index criteria than do hypertensive women; 
a finding paralleling the higher rate of cardiovascular disease 
events in men than in women with hypertension (42). This 
suggests that the absolute amount of myocardium might be 
lACC Vol 7. No J 
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more important to the risk of cardiovascular disease events 
than the ratio of left ventricular mass to the risk expected 
for individuals of a particular sex. 
Black hypertensive patients have a higher prevalence of 
left ventricular hypertrophy than do whites both by indexes 
of left ventricular mass and wall thickness. This tendency, 
which is consistent with earlier reports (43,44), is more 
striking in patients with borderline hypertension. Elevated 
left ventricular mass showed a twofold increase in preva•
lence between black and white hypertensive patients, while 
left ventricular hypertrophy manifested by increased relative 
wall thickness showed a threefold increase. This discrep•
ancy between black and white hypertensive patients is con•
sistent with a previous study (43) in which blacks had higher 
resistance and lower cardiac output than whites. These an•
atomic and hemodynamic observations are compatible with 
the known higher incidence of cardiovascular morbidity in 
black hypertensive patients than in white patients with sim•
ilar levels of casual blood pressure. In contrast, a higher 
proportion of white borderline and sustained hypertensive 
patients showed left ventricular chamber enlargement, sug•
gesting that volume overload in mild hypertension is more 
common among whites. This finding suggests that some of 
the differences reported in previous studies of prevalence 
of left ventricular hypertrophy and hemodynamic patterns 
(33,45-48) may be due to differences in racial composition 
of the study populations. 
Correlates of left ventricular hypertrophy; multivar•
iate analysis. In comparing patients with and without left 
ventricular hypertrophy by sex-specific echocardiographic 
criteria among our sustained hypertensive population, we 
found no difference in diastolic blood pressure and only a 
slightly higher level of systolic blood pressure. Thus, this 
finding is compatible with other studies that reported that 
the severity of hypertensive cardiovascular disease is not 
closely related to blood pressure levels. One explanation for 
the failure to relate left ventricular hypertrophy strongly to 
blood pressure level may be provided by the increased car•
diac output seen in hypertensive patients with left ventricular 
hypertrophy. These patients have both pressure overload of 
the left ventricle and an increased stroke volume, causing 
a greater hemodynamic stimulus to the development of left 
ventricular hypertrophy than provided by pure pressure 
overload. 
The apparent discrepancy between the present report of 
elevated cardiac output in patients with left ventricular hy•
pertrophy, and previous studies (49) suggesting that left 
ventricular hypertrophy was associated with reduction in 
cardiac output and damage to other target organs, may be 
explained by patient selection. All subjects in this study 
were actively employed and had to be considered able on 
the basis of clinical judgment. to be withdrawn from anti•
hypertensive drugs or cardiac active drugs. Thus, individ•
uals in whom left ventricular hypertrophy was associated 
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with impaired circulatory function and reduced cardiac out•
put would have been disproportionately excluded from the 
present study. 
We thank Damel D Savage. MD. PhD for hi' cnllcal review of thiS 
manu,cnpt. 
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